The Proof with Simon Hill cover image

New heart disease test you should order | Thomas Dayspring, Md

The Proof with Simon Hill

00:00

Advancements in Heart Disease Medications

This chapter explores the development of drugs targeting heart disease, specifically CETP inhibitors and their effects on major adverse cardiovascular events and lipoprotein(a) levels. It highlights promising treatments like anisetropib and obisetropib, while also discussing the complexities of drug regulation and the need for extensive research. The conversation emphasizes the significance of lifestyle changes and traditional therapies like aspirin in managing cardiovascular risks associated with elevated lipoprotein(a).

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app